Effect of Exercise on Renal Function in Predialysis

June 3, 2014 updated by: King's College Hospital NHS Trust

The Effect of Exercise on Renal Function and Cardiovascular Disease in Pre-dialysis (Chronic Kidney Disease Stage 3-4) Patients With Chronic Kidney Disease; a Randomised Controlled Trial Pilot Study.

The proposed research aims to examine whether regular aerobic exercise can preserve renal function, improve aerobic capacity, physical and psychosocial function, strength, cardiovascular function, general well-being and quality of life. Ultimately, the research aims to prove that exercise is a more cost-effective and a more efficient use or healthcare resources used in the treatment of patients with CKD. Exercise is a relatively cheap treatment option which is readily available and accessible for this patient population. establish if, compared with usual care, an exercise programme for pre-dialysis CKD patients;

  1. Preserves renal function.
  2. Improves aerobic capacity, physical and psychosocial function, strength, cardiovascular function, general well-being and quality of life.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • London, United Kingdom, SE5 9RS
        • King's College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • - Stages 3-4 chronic kidney disease (CKD) patients (glomerular filtration rate (GFR) 20-60 mL/min)
  • Male or female
  • Aged >18 years
  • Written informed consent

Exclusion Criteria:

  • Pregnancy

    • Requiring support for ambulation less than 20m
    • Vasculitis,
    • Proliferative diabetic retinopathy,
    • Severe osteodystrophy,
    • Uncontrolled diabetes,
    • Psychiatric illness, including anxiety, mood and untreated eating disorders
    • Infection or course of antibiotics within the last month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care
Active Comparator: Exercise
exercise intervention
The intervention will include 2 sessions of gym-based exercise per week, both of which will be supervised for 3 months, supervision will then decrease to once-weekly until 6 months, and then be through phone support for the remaining 6 months. Warm up and cool down of minimum of five minutes on stationary exercise cycle, rate of perceived exertion (RPE) ~11, followed by gentle stretching. Progressive resistance training (PRT) will use eight PRT machines training large muscle groups (e.g. bench press, latissimus pulldown, bicep curl, triceps pull down, leg press, knee extension, hamstring curl, calf raises). Intensity will be 80% of one repetition maximum (1RM), building up to 3 sets of 8 repetitions. 1RM will be re-assessed monthly, and program adjusted accordingly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
kidney function
Time Frame: up to 12 months
estimated glomerular filtration rate (egfr) creatinine
up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardio-respiratory fitness testing (VO2peak)
Time Frame: Baseline, 6 and 12 months
cycle ergometer
Baseline, 6 and 12 months
Pulse Wave Velocity (arterial stiffness)
Time Frame: Baseline, 6 and 12 months
Vicorder equipment, carotid-femoral region.
Baseline, 6 and 12 months
Body mass index (BMI)
Time Frame: Baseline, 6 and 12 months
Baseline, 6 and 12 months
weight
Time Frame: Baseline, 6 and 12 months
Baseline, 6 and 12 months
Waist circumference
Time Frame: Baseline, 6 and 12 months
Baseline, 6 and 12 months
Duke's activity status index
Time Frame: Baseline, 6 and 12 months
questionnaire
Baseline, 6 and 12 months
Short Form 36 questionnaire
Time Frame: Baseline, 6 and 12 months
Baseline, 6 and 12 months
Total cholesterol
Time Frame: Baseline, 6 and 12 months
Baseline, 6 and 12 months
High sensitivity c-reactive protein (Hs CRP)
Time Frame: Baseline, 6 and 12 months
Baseline, 6 and 12 months
Blood pressure
Time Frame: Baseline, 6 and 12 months
Baseline, 6 and 12 months
Resting heart rate (HR)
Time Frame: Baseline, 6 and 12 months
Baseline, 6 and 12 months
Triglycerides
Time Frame: baseline, 6 and 12 months
baseline, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: sharlene greenwood, Bsc, King's College Hospital NHS Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2011

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

May 27, 2014

First Submitted That Met QC Criteria

June 3, 2014

First Posted (Estimate)

June 4, 2014

Study Record Updates

Last Update Posted (Estimate)

June 4, 2014

Last Update Submitted That Met QC Criteria

June 3, 2014

Last Verified

June 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Disease

Clinical Trials on Exercise

Subscribe